Toronto Dominion Bank’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
– Sell
-8,300
Closed -$2.32M – 1927
2025
Q2
$2.32M Hold
8,300
– – ﹤0.01% 937
2025
Q1
$2.59M Buy
+8,300
New +$2.45M 0.01% 872
2019
Q3
– Sell
-8,000
Closed -$1.47M – 1446
2019
Q2
$1.47M Buy
8,000
+3,000
+60% +$537K ﹤0.01% 879
2019
Q1
$950K Buy
5,000
+500
+11% +$95.5K ﹤0.01% 997
2018
Q4
$876K Buy
+4,500
New +$878K ﹤0.01% 921
2018
Q3
– Sell
-14,200
Closed -$2.71M – 1379
2018
Q2
$2.71M Buy
+14,200
New +$2.51M 0.01% 784
2017
Q2
– Sell
-164,000
Closed -$26.9M – 1201
2017
Q1
$26.9M Buy
164,000
+48,200
+42% +$8.01M 0.07% 136
2016
Q4
$16.9M Buy
+115,800
New +$17.4M 0.05% 145

Other funds holding AMGN

Toronto Dominion Bank's AMGN Position: Q2 2026 in Review

Toronto Dominion Bank increased its Amgen (AMGN) stake by 8.9% in Q2 2026, buying an estimated $5.08M and bringing the position to 181,652 shares worth $65.8M. The position accounts for 0.08% of the portfolio, ranked #231.

Toronto Dominion Bank first reported a position in AMGN in Q2 2013 and has held it in 53 quarters since. The position peaked at $173M in Q4 2021. 3,164 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

  • Toronto Dominion Bank held 181,652 shares of Amgen worth $65.8M as of Q2 2026.
  • Toronto Dominion Bank bought 14,826 Amgen shares in Q2 2026, an estimated $5.08M.
  • Amgen made up 0.08% of Toronto Dominion Bank's portfolio in Q2 2026, its #231 holding.
  • Toronto Dominion Bank first reported a position in Amgen in Q2 2013 and has held it in 53 quarters since.
  • Toronto Dominion Bank's Amgen position peaked at $173M in Q4 2021.
  • 3,164 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on Toronto Dominion Bank's 13F filing for Q2 2026, filed 14 Aug 2026.